New cancer clinical trial: IMMU-132 in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy

Published on: October 31, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share